The Patent Finder

MediciNova, Inc.

Also on record
Records under this name other than the patents MediciNova, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 32 patents it holds.

Back to MediciNova, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,338,453Treatment of Progressive Neurodegenerative Disease with Ibudilast
No holder on record
In force
 · High confidence
In forceHigh confidence
US 7,534,806Method for Treating Neuropathic Pain and Associated Syndromes
Term ended
Term ended Dec 6, 2025 · High confidence
Term endedTerm ended Dec 6, 2025High confidence
US 7,429,617Phenoxyalkycarboxylic acid derivatives in the treatment of interstitial cystitis
Term ended
Term ended Sep 30, 2025 · USPTO record
Term endedTerm ended Sep 30, 2025USPTO record
US 7,786,169Phenoxyalkycarboxylic acid derivatives in the treatment of ulcerative colitis
Term ended
Term ended Apr 27, 2025 · USPTO record
Term endedTerm ended Apr 27, 2025USPTO record
US 8,026,282Phenoxyalkylcarboxylic acid derivatives in the treatment of irritable bowel syndrome
Term ended
Term ended Apr 27, 2025 · USPTO record
Term endedTerm ended Apr 27, 2025USPTO record
US 7,060,854Process for making polymorphic form A of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid
Term ended
Term ended Jun 24, 2023 · USPTO record
Term endedTerm ended Jun 24, 2023USPTO record
US 7,064,146Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of use
Term ended
Term ended Jun 24, 2023 · USPTO record
Term endedTerm ended Jun 24, 2023USPTO record
US 7,153,993Process for making polymorphic form A of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid
Term ended
Ended no later than Jun 24, 2023 · USPTO record
Term endedEnded no later than Jun 24, 2023USPTO record
US 7,365,224Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of use
Term ended
Ended no later than Jun 24, 2023 · USPTO record
Term endedEnded no later than Jun 24, 2023USPTO record
US 7,728,169Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of use
Term ended
Ended no later than Jun 24, 2023 · USPTO record
Term endedEnded no later than Jun 24, 2023USPTO record
10 of 12 patents shown.
Pro members see all 12.
Pro members: see all 12 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited